{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T10:49:30Z","timestamp":1784198970353,"version":"3.55.0"},"reference-count":63,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1093\/jnci\/dju048","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T03:32:38Z","timestamp":1396582358000},"source":"Crossref","is-referenced-by-count":169,"title":["Risk Prediction for Late-Stage Ovarian Cancer by Meta-analysis of 1525 Patient Samples"],"prefix":"10.1093","volume":"106","author":[{"given":"Markus","family":"Riester","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levi","family":"Waldron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aedin C.","family":"Culhane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Trippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung-hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Michor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis","family":"Huttenhower","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Parmigiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Birrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,4,3]]},"reference":[{"issue":"1","key":"key\n\t\t\t\t20170520222846_CIT0001","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"key\n\t\t\t\t20170520222846_CIT0002","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/IGC.0b013e3181cff38b","article-title":"Predicting the outcome of cytoreductive surgery for advanced ovarian cancer: a review","volume":"20","author":"Ibeanu","year":"2010","journal-title":"Int J Gynecol Cancer"},{"issue":"13","key":"key\n\t\t\t\t20170520222846_CIT0003","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1245\/s10434-012-2446-8","article-title":"Impact of complete cytoreduction leaving no gross residual disease associated with radical cytoreductive surgical procedures on survival in advanced ovarian cancer","volume":"19","author":"Chang","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"key\n\t\t\t\t20170520222846_CIT0004","volume-title":"Principles and Practice of Gynecologic Oncology","author":"Barakat","year":"2013","edition":"6th"},{"key":"key\n\t\t\t\t20170520222846_CIT0005","article-title":"curatedOvarianData: clinically annotated data for the ovarian cancer transcriptome","author":"Ganzfried","journal-title":"Database (Oxford)"},{"issue":"2","key":"key\n\t\t\t\t20170520222846_CIT0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030269","article-title":"Angiogenic mRNA and microRNA gene expression signature predicts a novel subtype of serous ovarian cancer","volume":"7","author":"Bentink","year":"2012","journal-title":"PLoS One"},{"issue":"22","key":"key\n\t\t\t\t20170520222846_CIT0007","doi-asserted-by":"crossref","first-page":"10602","DOI":"10.1158\/0008-5472.CAN-05-2240","article-title":"Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary","volume":"65","author":"Bonome","year":"2005","journal-title":"Cancer Res"},{"issue":"13","key":"key\n\t\t\t\t20170520222846_CIT0008","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1158\/0008-5472.CAN-07-6595","article-title":"A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer","volume":"68","author":"Bonome","year":"2008","journal-title":"Cancer Res"},{"issue":"7353","key":"key\n\t\t\t\t20170520222846_CIT0009","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","author":"Cancer Genome Atlas Research Network","year":"2011","journal-title":"Nature"},{"issue":"2","key":"key\n\t\t\t\t20170520222846_CIT0010","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000024","article-title":"Survival-related profile, pathways, and transcription factors in ovarian cancer","volume":"6","author":"Crijns","year":"2009","journal-title":"PLoS Med"},{"issue":"2","key":"key\n\t\t\t\t20170520222846_CIT0011","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/path.2547","article-title":"A prognostic gene expression index in ovarian cancer\u2014validation across different independent data sets","volume":"218","author":"Denkert","year":"2009","journal-title":"J Pathol"},{"issue":"10","key":"key\n\t\t\t\t20170520222846_CIT0012","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1158\/0008-5472.CAN-09-3912","article-title":"Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer","volume":"70","author":"Hernandez","year":"2010","journal-title":"Cancer Res"},{"issue":"6","key":"key\n\t\t\t\t20170520222846_CIT0013","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ccr.2009.10.018","article-title":"A gene signature predictive for outcome in advanced ovarian cancer identifies a survival factor: microfibril-associated glycoprotein 2","volume":"16","author":"Mok","year":"2009","journal-title":"Cancer Cell"},{"issue":"2","key":"key\n\t\t\t\t20170520222846_CIT0014","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/bjc.2011.219","article-title":"A seven-gene prognostic model for platinum-treated ovarian carcinomas","volume":"105","author":"Sabatier","year":"2011","journal-title":"Br J Cancer"},{"issue":"3","key":"key\n\t\t\t\t20170520222846_CIT0015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009615","article-title":"Gene expression profile for predicting survival in advanced-stage serous ovarian cancer across two independent datasets","volume":"5","author":"Yoshihara","year":"2010","journal-title":"PLoS One"},{"issue":"5","key":"key\n\t\t\t\t20170520222846_CIT0016","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1158\/1078-0432.CCR-11-2725","article-title":"High-risk ovarian cancer based on 126-gene expression signature is uniquely characterized by downregulation of antigen presentation pathway","volume":"18","author":"Yoshihara","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20170520222846_CIT0017","author":"Waldron"},{"issue":"1","key":"key\n\t\t\t\t20170520222846_CIT0018","first-page":"517","article-title":"Prognostically relevant gene signatures of high-grade serous ovarian carcinoma","volume":"123","author":"Verhaak","year":"2012","journal-title":"J Clin Invest"},{"issue":"16","key":"key\n\t\t\t\t20170520222846_CIT0019","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1016\/j.ejca.2006.06.026","article-title":"Expression analysis of stage III serous ovarian adenocarcinoma distinguishes a sub-group of survivors","volume":"42","author":"Partheen","year":"2006","journal-title":"Eur J Cancer"},{"issue":"4","key":"key\n\t\t\t\t20170520222846_CIT0020","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1037\/1082-989X.3.4.486","article-title":"Fixed- and random-effects models in meta-analysis","volume":"3","author":"Hedges","year":"1998","journal-title":"Psychol Meth"},{"issue":"3","key":"key\n\t\t\t\t20170520222846_CIT0021","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3102\/10769986030003261","article-title":"Bias and efficiency of meta-analytic variance estimators in the random-effects model","volume":"30","author":"Viechtbauer","year":"2005","journal-title":"J Educ Behav Stat"},{"issue":"4","key":"key\n\t\t\t\t20170520222846_CIT0022","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/0197-2456(93)90225-3","article-title":"Tightening the clinical trial","volume":"14","author":"Tukey","year":"1993","journal-title":"Control Clin Trials"},{"issue":"3","key":"key\n\t\t\t\t20170520222846_CIT0023","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2307\/2531595","article-title":"Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach","volume":"44","author":"DeLong","year":"1988","journal-title":"Biometrics"},{"issue":"10","key":"key\n\t\t\t\t20170520222846_CIT0024","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1002\/sim.4154","article-title":"On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data","volume":"30","author":"Uno","year":"2011","journal-title":"Stat Med"},{"issue":"4","key":"key\n\t\t\t\t20170520222846_CIT0025","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.ajog.2004.02.005","article-title":"Prediction of optimal versus suboptimal cytoreduction of advanced-stage serous ovarian cancer with the use of microarrays","volume":"190","author":"Berchuck","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"key\n\t\t\t\t20170520222846_CIT0026","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/bjc.2012.376","article-title":"Does tumour biology determine surgical success in the treatment of epithelial ovarian cancer? A systematic literature review","volume":"107","author":"Borley","year":"2012","journal-title":"Br J Cancer"},{"issue":"16","key":"key\n\t\t\t\t20170520222846_CIT0027","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1200\/JCO.2006.09.0795","article-title":"Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas","volume":"25","author":"Birrer","year":"2007","journal-title":"J Clin Oncol"},{"issue":"11","key":"key\n\t\t\t\t20170520222846_CIT0028","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1158\/1078-0432.CCR-12-0056","article-title":"Multidrug resistance-linked gene signature predicts overall survival of patients with primary ovarian serous carcinoma","volume":"18","author":"Gillet","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"5","key":"key\n\t\t\t\t20170520222846_CIT0029","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1200\/JCO.2006.06.3743","article-title":"An integrated genomic-based approach to individualized treatment of patients with advanced-stage ovarian cancer","volume":"25","author":"Dressman","year":"2007","journal-title":"J Clin Oncol"},{"issue":"22","key":"key\n\t\t\t\t20170520222846_CIT0030","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1200\/JCO.2009.27.5719","article-title":"Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer","volume":"28","author":"Konstantinopoulos","year":"2010","journal-title":"J Clin Oncol"},{"issue":"8","key":"key\n\t\t\t\t20170520222846_CIT0031","doi-asserted-by":"crossref","first-page":"e42413","DOI":"10.1371\/journal.pone.0042413","article-title":"SPARC is a key regulator of proliferation, apoptosis and invasion in human ovarian cancer","volume":"7","author":"Chen","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"key\n\t\t\t\t20170520222846_CIT0032","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10555-006-7886-9","article-title":"Matrix metalloproteinases and tumor metastasis","volume":"25","author":"Deryugina","year":"2006","journal-title":"Cancer Metastasis Rev"},{"issue":"13","key":"key\n\t\t\t\t20170520222846_CIT0033","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1038\/onc.2010.532","article-title":"Ligand-independent activation of c-Met by fibronectin and alpha(5)beta(1)-integrin regulates ovarian cancer invasion and metastasis","volume":"30","author":"Mitra","year":"2011","journal-title":"Oncogene"},{"issue":"6","key":"key\n\t\t\t\t20170520222846_CIT0034","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1586\/erm.11.47","article-title":"Cancer therapy trials employing level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1","volume":"11","author":"Schmitt","year":"2011","journal-title":"Expert Rev Mol Diagn"},{"issue":"1","key":"key\n\t\t\t\t20170520222846_CIT0035","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2353\/ajpath.2010.090748","article-title":"Metastatic outgrowth encompasses COL-I, FN1, and POSTN up-regulation and assembly to fibrillar networks regulating cell adhesion, migration, and growth","volume":"177","author":"Soikkeli","year":"2010","journal-title":"Am J Pathol"},{"issue":"2","key":"key\n\t\t\t\t20170520222846_CIT0036","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.biopha.2012.10.003","article-title":"The urokinase plasminogen activator system in breast cancer invasion and metastasis","volume":"67","author":"Tang","year":"2013","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"key\n\t\t\t\t20170520222846_CIT0037","doi-asserted-by":"crossref","first-page":"10461","DOI":"10.3390\/ijms130810461","article-title":"Transforming growth factor-beta-induced protein (TGFBI)\/(betaig-H3): a matrix protein with dual functions in ovarian cancer","volume":"13","author":"Ween","year":"2012","journal-title":"Int J Mol Sci"},{"issue":"16","key":"key\n\t\t\t\t20170520222846_CIT0038","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1158\/0008-5472.CAN-13-0023","article-title":"TGF-beta modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment","volume":"73","author":"Yeung","year":"2013","journal-title":"Cancer Res"},{"issue":"2","key":"key\n\t\t\t\t20170520222846_CIT0039","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1158\/0008-5472.CAN-12-2447","article-title":"Lysyl oxidase plays a critical role in endothelial cell stimulation to drive tumor angiogenesis","volume":"73","author":"Baker","year":"2013","journal-title":"Cancer Res"},{"issue":"69","key":"key\n\t\t\t\t20170520222846_CIT0040","first-page":"105","article-title":"Hedgehog pathway and GLI1 isoforms in human cancer","volume":"13","author":"Carpenter","year":"2012","journal-title":"Discov Med"},{"issue":"6","key":"key\n\t\t\t\t20170520222846_CIT0041","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/jcb.21194","article-title":"Functional properties and intracellular signaling of CCN1\/Cyr61","volume":"100","author":"Chen","year":"2007","journal-title":"J Cell Biochem"},{"issue":"1","key":"key\n\t\t\t\t20170520222846_CIT0042","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4161\/cc.3.1.604","article-title":"Early growth response-1: blocking angiogenesis by shooting the messenger","volume":"3","author":"Khachigian","year":"2004","journal-title":"Cell Cycle"},{"key":"key\n\t\t\t\t20170520222846_CIT0043","doi-asserted-by":"crossref","first-page":"4848","DOI":"10.2741\/3573","article-title":"Transforming growth factor-beta signaling and tumor angiogenesis","volume":"14","author":"Pardali","year":"2009","journal-title":"Front Biosci"},{"issue":"6","key":"key\n\t\t\t\t20170520222846_CIT0044","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1096\/fj.03-0545fje","article-title":"Versican\/PG-M G3 domain promotes tumor growth and angiogenesis","volume":"18","author":"Zheng","year":"2004","journal-title":"FASEB J"},{"issue":"2","key":"key\n\t\t\t\t20170520222846_CIT0045","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ygyno.2010.07.008","article-title":"Periostin promotes ovarian cancer angiogenesis and metastasis","volume":"119","author":"Zhu","year":"2010","journal-title":"Gynecol Oncol"},{"issue":"1","key":"key\n\t\t\t\t20170520222846_CIT0046","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ccr.2008.11.012","article-title":"Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche","volume":"15","author":"Erler","year":"2009","journal-title":"Cancer Cell"},{"issue":"19","key":"key\n\t\t\t\t20170520222846_CIT0047","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1158\/0008-5472.CAN-12-1223","article-title":"Microenvironmental regulation of epithelial-mesenchymal transitions in cancer","volume":"72","author":"Gao","year":"2012","journal-title":"Cancer Res"},{"issue":"7379","key":"key\n\t\t\t\t20170520222846_CIT0048","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nature10694","article-title":"Interactions between cancer stem cells and their niche govern metastatic colonization","volume":"481","author":"Malanchi","year":"2012","journal-title":"Nature"},{"issue":"6","key":"key\n\t\t\t\t20170520222846_CIT0049","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2174\/156800908785699360","article-title":"Tumor stroma as a target in cancer","volume":"8","author":"Ahmed","year":"2008","journal-title":"Curr Cancer Drug Targets"},{"issue":"5","key":"key\n\t\t\t\t20170520222846_CIT0050","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1593\/neo.101720","article-title":"Cancer-associated fibroblasts and their putative role in potentiating the initiation and development of epithelial ovarian cancer","volume":"13","author":"Schauer","year":"2011","journal-title":"Neoplasia"},{"issue":"1","key":"key\n\t\t\t\t20170520222846_CIT0051","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1158\/1078-0432.CCR-07-0443","article-title":"How large a training set is needed to develop a classifier for microarray data?","volume":"14","author":"Dobbin","year":"2008","journal-title":"Clin Cancer Res"},{"issue":"14","key":"key\n\t\t\t\t20170520222846_CIT0052","doi-asserted-by":"crossref","first-page":"14ps2","DOI":"10.1126\/scitranslmed.3000313","article-title":"Why most gene expression signatures of tumors have not been useful in the clinic","volume":"2","author":"Koscielny","year":"2010","journal-title":"Sci Transl Med"},{"key":"key\n\t\t\t\t20170520222846_CIT0053","doi-asserted-by":"crossref","DOI":"10.17226\/13297","volume-title":"Evolution of Translational Omics Lessons Learned and the Path Forward","author":"Micheel","year":"2012"},{"issue":"2","key":"key\n\t\t\t\t20170520222846_CIT0054","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.critrevonc.2009.01.007","article-title":"Gene expression profiling and prediction of clinical outcome in ovarian cancer","volume":"72","author":"Sabatier","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"issue":"12","key":"key\n\t\t\t\t20170520222846_CIT0055","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/jnci\/dji168","article-title":"Development and validation of therapeutically relevant multi-gene biomarker classifiers","volume":"97","author":"Simon","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"key\n\t\t\t\t20170520222846_CIT0056","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1214\/09-AOAS291","article-title":"Deriving chemosensitivity from cell lines: forensic bioinformatics and reproducible research in high-throughput biology","volume":"3","author":"Baggerly","year":"2009","journal-title":"Ann Appl Stat"},{"issue":"7","key":"key\n\t\t\t\t20170520222846_CIT0057","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1200\/JCO.2007.15.1951","article-title":"Run batch effects potentially compromise the usefulness of genomic signatures for ovarian cancer","volume":"26","author":"Baggerly","year":"2008","journal-title":"J Clin Oncol"},{"issue":"10","key":"key\n\t\t\t\t20170520222846_CIT0058","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/nrg2825","article-title":"Tackling the widespread and critical impact of batch effects in high-throughput data","volume":"11","author":"Leek","year":"2010","journal-title":"Nat Rev Genet"},{"issue":"9","key":"key\n\t\t\t\t20170520222846_CIT0059","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1093\/jnci\/djs203","article-title":"Molecular scores to predict ovarian cancer outcomes: a worthy goal, but not ready for prime time","volume":"104","author":"Swisher","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"10","key":"key\n\t\t\t\t20170520222846_CIT0060","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"issue":"11","key":"key\n\t\t\t\t20170520222846_CIT0061","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1517\/14728222.2010.525353","article-title":"TGF-beta: friend or foe? The role of TGF-beta\/SMAD signaling in epigenetic silencing of ovarian cancer and its implication in epigenetic therapy","volume":"14","author":"Chou","year":"2010","journal-title":"Expert Opin Ther Targets"},{"issue":"17","key":"key\n\t\t\t\t20170520222846_CIT0062","doi-asserted-by":"crossref","first-page":"8404","DOI":"10.1158\/0008-5472.CAN-06-0683","article-title":"Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer","volume":"66","author":"Sunde","year":"2006","journal-title":"Cancer Res"},{"issue":"16","key":"key\n\t\t\t\t20170520222846_CIT0063","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-08-0196","article-title":"Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome","volume":"14","author":"Tothill","year":"2008","journal-title":"Clin Cancer Res"}],"container-title":["JNCI: Journal of the National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jnci\/article-pdf\/106\/5\/dju048\/17313240\/dju048.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T19:19:49Z","timestamp":1648754389000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jnci\/article-lookup\/doi\/10.1093\/jnci\/dju048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,3]]},"references-count":63,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2014,4,3]]},"published-print":{"date-parts":[[2014,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jnci\/dju048","relation":{},"ISSN":["1460-2105","0027-8874"],"issn-type":[{"value":"1460-2105","type":"electronic"},{"value":"0027-8874","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4,3]]}}}